Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003726 · ClinicalTrials.gov registry record · Phase 1
Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer
A Phase 1 study, sponsored by Dartmouth-Hitchcock Medical Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT00003726: Clinical Trial Phase 1 study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT00003726 is a Phase 1 study that was terminated before completion, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 1 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003726, a Phase 1 study, was terminated before completion, sponsored by Dartmouth-Hitchcock Medical Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
RATIONALE: Anticoagulants, such as lepirudin, may help prevent blood clots from forming in patients who have received chemotherapy for small cell lung cancer. PURPOSE: This phase I/II trial is studying the side effects and best dose of lepirudin in treating patients with recurrent or advanced small cell lung cancer.
Primary Outcome
Evaluated through clinical exams, tumor assessments, laboratory assessment, and adverse event assessments.
Interventions
- BIOLOGICAL lepirudin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 1998-11 |
| Est. Completion | 2001-07 |
| Phase | Phase 1 |
Why NCT00003726 stopped before completion
NCT00003726 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which lepirudin is the first listed.
NCT00003726 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003726 about?
NCT00003726 is a clinical study titled "Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer". RATIONALE: Anticoagulants, such as lepirudin, may help prevent blood clots from forming in patients who have received chemotherapy for small cell lung cancer. PURPOSE: This phase I/II trial is studying the side effects and best dose of lepirudin in treating patients with recurrent or advanced small...
What is the current status of trial NCT00003726?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 1998-11. Estimated completion is 2001-07.
What interventions are being tested in trial NCT00003726?
The interventions under investigation include: lepirudin (BIOLOGICAL).
Who is sponsoring clinical trial NCT00003726?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00003726's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia